MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$65,858K
Prepaid expenses and
other current assets
$4,243K
Restricted cash
$1,331K
Research and development
incentives receivable
$1,232K
Total current assets
$72,664K
Intangible assets, net
$13,666K
Property and equipment,
net
$3,270K
Right of use assets,
net
$1,629K
Other assets
$914K
Total assets
$92,143K
Total liabilities and
stockholders equity
$92,143K
Total stockholders
equity
$66,478K
Total liabilities
$25,665K
Total stockholders
equity attributable to...
$66,399K
Noncontrolling interest
$79K
Total current
liabilities
$12,001K
Operating lease liability
- non-current
$9,003K
Contingent consideration
$2,956K
Other non-current
liabilities
$1,468K
Deferred tax liability,
net
$237K
Accumulated deficit
-$309,628K
Accumulated other
comprehensive loss foreign...
-$18,559K
Additional paid-in capital
$394,499K
Accrued expenses and
other current...
$8,685K
Operating lease liability
- current
$2,005K
Accounts payable
$993K
Deferred income
$318K
Deferred a shares, 1
nominal value 63,443...
$86K
Ordinary shares,
0.000025 nominal value...
$1K
Back
Back
Balance Sheet
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)
source: myfinsight.com